scholarly journals Impact of evidence-based healthcare education for Chinese medicine practitioners:Pre-post evaluation

2021 ◽  
Vol 48 ◽  
pp. 101988
Author(s):  
Vincent C.H. Chung ◽  
Wenbo Peng ◽  
Charlene H.L. Wong ◽  
Irene X.Y. Wu ◽  
Matthew J. Leach ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Evidence Based ◽  
Healthcare Education ◽  
Post Evaluation ◽  
Evidence Based Healthcare

Impact of evidence-based healthcare education for Chinese medicine practitioners: A pre-post evaluation

2019 ◽  
Vol 45 ◽  
pp. 38-44 ◽  
Author(s):  
Charlene H.L. Wong ◽  
Irene X.Y. Wu ◽  
William K.W. Cheung ◽  
Robin S.T. Ho ◽  
Matthew J. Leach ◽  
...  
Keyword(s):  
Chinese Medicine ◽  
Evidence Based ◽  
Healthcare Education ◽  
Post Evaluation ◽  
Evidence Based Healthcare

scholarly journals Barriers and facilitators to promoting evidence uptake in Chinese medicine: a qualitative study in Hong Kong

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Charlene Hoi Lam Wong ◽  
Jeffrey Van Ho Tse ◽  
Per Nilsen ◽  
Leonard Ho ◽  
Irene Xin Yin Wu ◽  
...  
Keyword(s):  
Hong Kong ◽  
Chinese Medicine ◽  
Randomized Trials ◽  
Clinical Evidence ◽  
Barriers And Facilitators ◽  
World Health ◽  
Routine Practice ◽  
Evidence Based ◽  
The World ◽  
Evidence Based Healthcare

Abstract Background In response to the World Health Organization’s recommendation, policy makers have been adopting evidence-based healthcare approach to promote the development of traditional, complementary and integrative medicine (TCIM) into Hong Kong’s health system. Disseminating synopses of clinical evidence from systematic reviews or randomized trials is regarded as a potentially effective strategy to promote evidence uptake. The study aimed to identify barriers and facilitators to implementing this strategy among Hong Kong Chinese medicine practitioners (CMPs). Methods Twenty-five CMPs aged under 45 years and trained in Hong Kong after reunification with China in 1997 were interviewed individually. Four clinical evidence synopses of randomized trials and systematic reviews on Chinese medicine interventions were presented, and CMPs were asked to comment on their applicability in routine practice. The Consolidated Framework for Implementation Research (CFIR) was applied to guide interview and analysis. Results The barriers included: i) CMPs’ perceived difficulties in applying complex evidence in decision-making and ii) inadequate training and limited consultation time. The facilitators were i) availability of publicly accessible and user-friendly synopses, ii) formation of community of evidence-based practice among CMPs with input from key opinion leaders, iii) opportunity for interprofessional collaborations with conventional healthcare providers, and iv) patients’ demand for evidence-based clinical advice. Besides, i) CMPs’ knowledge and beliefs in evidence-based healthcare approach, ii) presentations of evidence-based information in the synopses, and iii) clinical decision making as influenced by quality of evidence reported acted as both barriers and facilitators. Conclusions This CFIR-based qualitative study investigated how the World Health Organization recommendation of promoting evidence use in routine practice was perceived by CMPs trained in Hong Kong after reunification with China in 1997. Key barriers and facilitators to applying evidence were identified. Such results will inform tailoring of implementation strategies for promoting evidence uptake, in the context of a well-developed health system dominated by conventional medicine.

Where next for evidence based healthcare?

BMJ ◽  
2013 ◽  
Vol 346 (feb06 1) ◽  
pp. f766-f766 ◽  
Author(s):  
C. Heneghan ◽  
F. Godlee
Keyword(s):  
Evidence Based ◽  
Evidence Based Healthcare

Evidence-based Clinical Chinese Medicine

10.1142/12306 ◽  
2021 ◽  
Author(s):  
Charlie Changli Xue ◽  
Chuanjian Lu ◽  
Brian H May ◽  
Yihong Liu
Keyword(s):  
Chinese Medicine ◽  
Evidence Based

scholarly journals Evidence-Based Chinese Medicine for Hypertension

2013 ◽  
Vol 2013 ◽  
pp. 1-12 ◽  
Author(s):  
Jie Wang ◽  
Xingjiang Xiong
Keyword(s):  
Chinese Medicine ◽  
Tai Chi ◽  
Clinical Evidence ◽  
Poor Quality ◽  
Evidence Based ◽  
Hypertensive Patients ◽  
Primary Endpoints ◽  
Potential Benefits ◽  
Public Health Challenge

Hypertension is an important worldwide public -health challenge with high mortality and disability. Due to the limitations and concerns with current available hypertension treatments, many hypertensive patients, especially in Asia, have turned to Chinese medicine (CM). Although hypertension is not a CM term, physicians who practice CM in China attempt to treat the disease using CM principles. A variety of approaches for treating hypertension have been taken in CM. For seeking the best evidence of CM in making decisions for hypertensive patients, a number of clinical studies have been conducted in China, which has paved the evidence-based way. After literature searching and analyzing, it appeared that CM was effective for hypertension in clinical use, such as Chinese herbal medicine, acupuncture, moxibustion, cupping, qigong, and Tai Chi. However, due to the poor quality of primary studies, clinical evidence is still weak. The potential benefits and safety of CM for hypertension still need to be confirmed in the future with well-designed RCTs of more persuasive primary endpoints and high-quality SRs. Evidence-based Chinese medicine for hypertension still has a long way to go.

Sign in / Sign up

Export Citation Format

Share Document